10-K Decoder · All companies

Relay Therapeutics, Inc.

RLAY · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$15.4M$10.0M+53.4%
Operating income−$303M−$372M+18.7%
Net income−$276M−$338M+18.1%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$90.2M−$80.4M−12.2%
Net income−$81.7M−$74.1M−10.3%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Relay's revenue in FY2025?
$15.4M in FY2025 (Fiscal year ended Dec 31, 2025), +53.4% vs $10.0M a year earlier, per its 10-K filed Feb 2026.
Was Relay profitable in FY2025?
No: net income was −$276M and operating income −$303M in FY2025.
What was Relay's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 4, 2026.